Literature DB >> 25961492

Comparison of galectin expression signatures in rejected and accepted murine corneal allografts.

Satoshi Sugaya1, Wei-Sheng Chen2, Zhiyi Cao1, Kenneth R Kenyon1,3, Takefumi Yamaguchi3, Masashiro Omoto3, Pedram Hamrah3, Noorjahan Panjwani1,2.   

Abstract

PURPOSE: Although members of the galectin family of carbohydrate-binding proteins are thought to play a role in the immune response and regulation of allograft survival, little is known about the galectin expression signature in failed corneal grafts. The aim of this study was to compare the galectin expression pattern in accepted and rejected murine corneal allografts.
METHODS: Using BALB/c mice as recipients and C57BL/6 mice as donors, a total of 57 transplants were successfully performed. One week after transplantation, the grafts were scored for opacity by slit-lamp microscopy. Opacity scores of 3+ or greater on postoperative week 4 were considered rejected. Grafted corneas were harvested on postoperative week 4, and their galectin expressions were analyzed by Western blot and immunofluorescence staining.
RESULTS: As determined by the Western blot analyses, galectins-1, 3, 7, 8 and 9 were expressed in normal corneas. Although in both accepted and rejected grafts, expression levels of the 5 lectins were upregulated compared with normal corneas, there were distinct differences in the expression levels of galectins-8 and 9 between accepted and rejected grafts, as both the Western blot and immunofluorescence staining revealed that galectin-8 is upregulated, whereas galectin-9 is downregulated in the rejected grafts compared with the accepted grafts.
CONCLUSIONS: Our findings that corneal allograft rejection is associated with increased galectin-8 expression and reduced galectin-9 expression, support the hypothesis that galectin-8 may reduce graft survival, whereas galectin-9 may promote graft survival. As a potential therapeutic intervention, inhibition of galectin-8 and/or treatment with exogenous galectin-9 may enhance corneal allograft survival rates.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25961492      PMCID: PMC4430336          DOI: 10.1097/ICO.0000000000000439

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  46 in total

1.  Corneal transplantation: how successful are we?

Authors:  A Waldock; S D Cook
Journal:  Br J Ophthalmol       Date:  2000-08       Impact factor: 4.638

Review 2.  Corneal transplantation.

Authors:  Donald T H Tan; John K G Dart; Edward J Holland; Shigeru Kinoshita
Journal:  Lancet       Date:  2012-05-05       Impact factor: 79.321

3.  Galectin-8 elicits pro-inflammatory activities in the endothelium.

Authors:  Valentina Cattaneo; María Virginia Tribulatti; Julieta Carabelli; Agostina Carestia; Mirta Schattner; Oscar Campetella
Journal:  Glycobiology       Date:  2014-06-22       Impact factor: 4.313

Review 4.  Therapeutic potential of Galectin-9 in human disease.

Authors:  Valerie R Wiersma; Marco de Bruyn; Wijnand Helfrich; Edwin Bremer
Journal:  Med Res Rev       Date:  2011-07-26       Impact factor: 12.944

5.  Galectin-7 in cardiac allografts in mice: increased expression compared with isografts and localization in infiltrating lymphocytes and vascular endothelial cells.

Authors:  Z Luo; Y Ji; H Zhou; X Huang; J Fang; H Guo; T Pan; Z K Chen
Journal:  Transplant Proc       Date:  2013-03       Impact factor: 1.066

6.  Soluble vascular endothelial growth factor receptor 3 is essential for corneal alymphaticity.

Authors:  Nirbhai Singh; Michelle Tiem; Ryan Watkins; Yang Kyung Cho; Ying Wang; Thomas Olsen; Hironori Uehara; Christina Mamalis; Ling Luo; Zackery Oakey; Balamurali K Ambati
Journal:  Blood       Date:  2013-03-08       Impact factor: 22.113

7.  Galectin-9 functionally impairs natural killer cells in humans and mice.

Authors:  Lucy Golden-Mason; Rachel H McMahan; Michael Strong; Richard Reisdorph; Spencer Mahaffey; Brent E Palmer; Linling Cheng; Caroline Kulesza; Mitsuomi Hirashima; Toshiro Niki; Hugo R Rosen
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

8.  Up-regulation of Galectin-9 in vivo results in immunosuppressive effects and prolongs survival of liver allograft in rats.

Authors:  Yi-Ming Liu; Yong Chen; Jin-Zheng Li; Jian-Ping Gong
Journal:  Immunol Lett       Date:  2014-09-08       Impact factor: 3.685

9.  Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Alison C MacKinnon; Xiaojun Liu; Patrick Wf Hadoke; Mark R Miller; David E Newby; Tariq Sethi
Journal:  Glycobiology       Date:  2013-02-19       Impact factor: 4.313

10.  Galectin-9-mediated protection from allo-specific T cells as a mechanism of immune privilege of corneal allografts.

Authors:  Machiko Shimmura-Tomita; Mingcong Wang; Hiroko Taniguchi; Hisaya Akiba; Hideo Yagita; Junko Hori
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

View more
  7 in total

1.  Galectins as Regulators of Corneal Inflammation.

Authors:  Pablo Argüeso
Journal:  Curr Opin Physiol       Date:  2020-09-07

2.  Galectin-3 Inhibition by a Small-Molecule Inhibitor Reduces Both Pathological Corneal Neovascularization and Fibrosis.

Authors:  Wei-Sheng Chen; Zhiyi Cao; Hakon Leffler; Ulf J Nilsson; Noorjahan Panjwani
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-01-01       Impact factor: 4.799

3.  Three kinds of corneal host cells contribute differently to corneal neovascularization.

Authors:  Haiyang Yu; Liyao Sun; Jing Cui; Yan Li; Yu Yan; Xi Wei; Chao Wang; Fanqian Song; Wentong Jiang; Yifan Liu; Hongyan Ge; Hua Qian; Xiaoguang Li; Xianling Tang; Ping Liu
Journal:  EBioMedicine       Date:  2019-05-22       Impact factor: 8.143

4.  Efficacy of Lamellar Keratoplasty with Acellular Porcine Corneal Stroma in Treatment for Infectious Central and Peripheral Corneal Ulcers.

Authors:  Yingxin Chen; Linlin Zhang; Zhiling Liu; Qiming Liu; Minghong Gao
Journal:  Ther Clin Risk Manag       Date:  2021-06-10       Impact factor: 2.423

5.  Pathological lymphangiogenesis is modulated by galectin-8-dependent crosstalk between podoplanin and integrin-associated VEGFR-3.

Authors:  Wei-Sheng Chen; Zhiyi Cao; Satoshi Sugaya; Maria J Lopez; Victor G Sendra; Nora Laver; Hakon Leffler; Ulf J Nilsson; Jianxin Fu; Jianhua Song; Lijun Xia; Pedram Hamrah; Noorjahan Panjwani
Journal:  Nat Commun       Date:  2016-04-12       Impact factor: 14.919

Review 6.  Lectin-Glycan Interactions in Corneal Infection and Inflammation.

Authors:  Dina B AbuSamra; Pablo Argüeso
Journal:  Front Immunol       Date:  2018-10-08       Impact factor: 7.561

7.  Structural insight into the binding of human galectins to corneal keratan sulfate, its desulfated form and related saccharides.

Authors:  Michelle C Miller; Chao Cai; Kanin Wichapong; Sayantan Bhaduri; Nicola L B Pohl; Robert J Linhardt; Hans-Joachim Gabius; Kevin H Mayo
Journal:  Sci Rep       Date:  2020-09-24       Impact factor: 4.996

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.